131 related articles for article (PubMed ID: 10561576)
1. NMR structure of the (1-51) N-terminal domain of the HIV-1 regulatory protein Vpr.
Wecker K; Roques BP
Eur J Biochem; 1999 Dec; 266(2):359-69. PubMed ID: 10561576
[TBL] [Abstract][Full Text] [Related]
2. NMR structure of the HIV-1 regulatory protein Vpr in H2O/trifluoroethanol. Comparison with the Vpr N-terminal (1-51) and C-terminal (52-96) domains.
Wecker K; Morellet N; Bouaziz S; Roques BP
Eur J Biochem; 2002 Aug; 269(15):3779-88. PubMed ID: 12153575
[TBL] [Abstract][Full Text] [Related]
3. NMR structure of the (52-96) C-terminal domain of the HIV-1 regulatory protein Vpr: molecular insights into its biological functions.
Schüler W; Wecker K; de Rocquigny H; Baudat Y; Sire J; Roques BP
J Mol Biol; 1999 Feb; 285(5):2105-17. PubMed ID: 9925788
[TBL] [Abstract][Full Text] [Related]
4. NMR structure of the HIV-1 regulatory protein VPR.
Morellet N; Bouaziz S; Petitjean P; Roques BP
J Mol Biol; 2003 Mar; 327(1):215-27. PubMed ID: 12614620
[TBL] [Abstract][Full Text] [Related]
5. Mutagenic analysis of human immunodeficiency virus type 1 Vpr: role of a predicted N-terminal alpha-helical structure in Vpr nuclear localization and virion incorporation.
Yao XJ; Subbramanian RA; Rougeau N; Boisvert F; Bergeron D; Cohen EA
J Virol; 1995 Nov; 69(11):7032-44. PubMed ID: 7474123
[TBL] [Abstract][Full Text] [Related]
6. Structural characterization of the HIV-1 Vpr N terminus: evidence of cis/trans-proline isomerism.
Bruns K; Fossen T; Wray V; Henklein P; Tessmer U; Schubert U
J Biol Chem; 2003 Oct; 278(44):43188-201. PubMed ID: 12881523
[TBL] [Abstract][Full Text] [Related]
7. Solution structure of the human immunodeficiency virus type 1 p6 protein.
Fossen T; Wray V; Bruns K; Rachmat J; Henklein P; Tessmer U; Maczurek A; Klinger P; Schubert U
J Biol Chem; 2005 Dec; 280(52):42515-27. PubMed ID: 16234236
[TBL] [Abstract][Full Text] [Related]
8. Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr.
Di Marzio P; Choe S; Ebright M; Knoblauch R; Landau NR
J Virol; 1995 Dec; 69(12):7909-16. PubMed ID: 7494303
[TBL] [Abstract][Full Text] [Related]
9. Solution structure of human immunodeficiency virus type 1 Vpr(13-33) peptide in micelles.
Engler A; Stangler T; Willbold D
Eur J Biochem; 2001 Jan; 268(2):389-95. PubMed ID: 11168374
[TBL] [Abstract][Full Text] [Related]
10. Structural studies of synthetic peptide fragments derived from the HIV-1 Vpr protein.
Luo Z; Butcher DJ; Murali R; Srinivasan A; Huang Z
Biochem Biophys Res Commun; 1998 Mar; 244(3):732-6. PubMed ID: 9535734
[TBL] [Abstract][Full Text] [Related]
11. Functional and structural characterization of synthetic HIV-1 Vpr that transduces cells, localizes to the nucleus, and induces G2 cell cycle arrest.
Henklein P; Bruns K; Sherman MP; Tessmer U; Licha K; Kopp J; de Noronha CM; Greene WC; Wray V; Schubert U
J Biol Chem; 2000 Oct; 275(41):32016-26. PubMed ID: 10903315
[TBL] [Abstract][Full Text] [Related]
12. Functional role of residues corresponding to helical domain II (amino acids 35 to 46) of human immunodeficiency virus type 1 Vpr.
Singh SP; Tomkowicz B; Lai D; Cartas M; Mahalingam S; Kalyanaraman VS; Murali R; Srinivasan A
J Virol; 2000 Nov; 74(22):10650-7. PubMed ID: 11044109
[TBL] [Abstract][Full Text] [Related]
13. Human immunodeficiency virus type 1 Vpr localization: nuclear transport of a viral protein modulated by a putative amphipathic helical structure and its relevance to biological activity.
Subbramanian RA; Yao XJ; Dilhuydy H; Rougeau N; Bergeron D; Robitaille Y; Cohen EA
J Mol Biol; 1998 Apr; 278(1):13-30. PubMed ID: 9571031
[TBL] [Abstract][Full Text] [Related]
14. Structure of human immunodeficiency virus type 1 Vpr(34-51) peptide in micelle containing aqueous solution.
Engler A; Stangler T; Willbold D
Eur J Biochem; 2002 Jul; 269(13):3264-9. PubMed ID: 12084067
[TBL] [Abstract][Full Text] [Related]
15. Solution structure of peptides from HIV-1 Vpr protein that cause membrane permeabilization and growth arrest.
Yao S; Torres AM; Azad AA; Macreadie IG; Norton RS
J Pept Sci; 1998 Nov; 4(7):426-35. PubMed ID: 9851370
[TBL] [Abstract][Full Text] [Related]
16. The putative alpha helix 2 of human immunodeficiency virus type 1 Vpr contains a determinant which is responsible for the nuclear translocation of proviral DNA in growth-arrested cells.
Nie Z; Bergeron D; Subbramanian RA; Yao XJ; Checroune F; Rougeau N; Cohen EA
J Virol; 1998 May; 72(5):4104-15. PubMed ID: 9557700
[TBL] [Abstract][Full Text] [Related]
17. Nucleocytoplasmic shuttling by human immunodeficiency virus type 1 Vpr.
Sherman MP; de Noronha CM; Heusch MI; Greene S; Greene WC
J Virol; 2001 Feb; 75(3):1522-32. PubMed ID: 11152524
[TBL] [Abstract][Full Text] [Related]
18. Analysis of HIV-1 Vpr determinants responsible for cell growth arrest in Saccharomyces cerevisiae.
Yao XJ; Rougeau N; Duisit G; Lemay J; Cohen EA
Retrovirology; 2004 Aug; 1():21. PubMed ID: 15312229
[TBL] [Abstract][Full Text] [Related]
19. Partner molecules of accessory protein Vpr of the human immunodeficiency virus type 1.
Kino T; Pavlakis GN
DNA Cell Biol; 2004 Apr; 23(4):193-205. PubMed ID: 15142377
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a leucine-zipper-like domain in Vpr protein of human immunodeficiency virus type 1.
Wang L; Mukherjee S; Narayan O; Zhao LJ
Gene; 1996 Oct; 178(1-2):7-13. PubMed ID: 8921884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
